Update in Blood Purification: EUPHRATES trial

Authors

  • ณัฏฐา ล้ำเลิศกุล หน่วยโรคไต คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย

References

Srisawat N, Tungsanga S, Lumlertgul N, Komaenthammasophon C, Peerapornratana S, Thamrongsat N, et al. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients. Crit Care. 2018 Oct 26; 22(1): 279.

Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshal JC, et al. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients with Septic Shock and Elevated Endotoxin Level. JAMA. 2018;320(14): 1455 - 1463.

Iba T and Fowler L. Is Polymyxin B-immobilized Fiber Column Ineffective for Septic Shock? Discussion on the Press Release for EUPHRATES Trial. J Intensive Care. 2017; 5:40.

Downloads

Published

2019-06-24

How to Cite

1.
ล้ำเลิศกุล ณ. Update in Blood Purification: EUPHRATES trial. Clin Crit Care [Internet]. 2019 Jun. 24 [cited 2024 Nov. 18];27(1):7-8. Available from: https://he02.tci-thaijo.org/index.php/ccc/article/view/250289

Issue

Vol. 27 No. 1 (2019): January - June

Section

RRT Tips and Tricks